Europe Celiac Disease Market was valued at USD 1.4 Billion in 2022 and is projected to reach USD 2.3 Billion by 2030, growing at a CAGR of 7.0% from 2024 to 2030.
The European celiac disease market is experiencing significant growth, driven by increased awareness, improved diagnostics, and a rising prevalence of the condition. This surge has led to a heightened demand for gluten-free products, specialized therapies, and advanced diagnostic tools. Notably, major pharmaceutical companies such as Takeda, ImmunogenX, Precigen ActoBio, Falk Pharma, Zedira, and 9 Meters Biopharma are actively developing innovative treatments to meet the evolving needs of this expanding market.
In 2023, Italy led the celiac disease market among the EU4 and the UK, with an estimated market value of approximately USD 200 million. Germany's celiac disease treatment market generated a revenue of USD 38.4 million in 2024 and is expected to reach USD 68.6 million by 2030, growing at a CAGR of 10.1% from 2025 to 2030. This growth is attributed to the rising number of geriatrics, more active lifestyles in European countries, and technological developments in healthcare.
Vitamins and minerals dominated the treatment market, accounting for the largest revenue share of 39.9% in 2024. This is driven by individuals with celiac disease who often experience nutrient deficiencies due to the malabsorption of essential vitamins and minerals caused by intestinal damage. Supplementation with targeted vitamins and minerals helps address these deficiencies and supports overall health. Furthermore, the increasing availability of specialized vitamin and mineral supplements formulated for celiac patients has expanded treatment options.
Gluten-degrading enzymes are projected to grow at a CAGR of 13.9% over the forecast period. Individuals with celiac disease require a strict gluten-free diet to manage their symptoms. However, there is a growing demand for gluten-free products worldwide because of the increasing prevalence of celiac disease and other food allergies. The increased consumption of gluten-free products such as bread, cookies, and other bakery items in restaurants, cafés, and home-cooked meals has aided segment growth.
Retail pharmacies held the largest revenue share of 39.9% in 2024. Retail pharmacies, including independent and chain establishments, are crucial in ensuring accessible access to medications, vitamins, and over-the-counter products for individuals with celiac disease. This sector is anticipated to experience substantial growth, fueled by the increasing demand for gluten-free items, nutritional supplements, and essential medicines required for effective management of the condition.
The European Union has implemented stringent regulations and labeling standards for gluten-free products. The European Union's legislation mandates that any product labeled as gluten-free must contain less than 20 parts per million (ppm) of gluten. This strict standard ensures that individuals with celiac disease or gluten intolerance can trust the accuracy of gluten-free labels and make informed choices about the products they consume. Additionally, the EU Regulation 1169/2011 requires that all pre-packaged foods, including gluten-free products, provide clear and accurate information about the presence of allergens, including gluten. The ingredients list must clearly indicate the presence of any gluten-containing ingredients, and if the product is labeled as gluten-free, it must meet the criteria specified in Regulation 828/2014.
In 2021, the Association of European Coeliac Societies (AOECS) and BRCGS joined forces to promote greater access to safe and reliable gluten-free products in Europe. This collaboration opens up new opportunities for food companies that want to promote their gluten-free brands in all 37 European territories covered by the AOECS. This partnership applies to processed foods and ingredients used by food manufacturing companies, ensuring that consumers have access to safe and reliable gluten-free options.
In conclusion, the European celiac disease market is witnessing substantial growth, driven by increased awareness, improved diagnostics, and a rising prevalence of the condition. The collaboration between organizations like AOECS and BRCGS, along with stringent EU regulations, ensures that individuals with celiac disease have access to safe and reliable gluten-free products. As the market continues to expand, industries must adapt to meet the evolving needs of consumers seeking trustworthy gluten-free options.
Get an In-Depth Research Analysis of the Europe Celiac Disease Market Size And Forecast [2025-2032]
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
Immunomedics
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Celiac Disease Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Celiac Disease Market
Gluten-Free Grains
Gluten-Free Snacks
Gluten-Free Dairy Products
Gluten-Free Soups and Sauces
Gluten-Free Baked Goods
Supermarkets/Hypermarkets
Health Food Stores
Online Retail
Specialty Stores
Direct Sales
Adults
Children
Senior Citizens
Infants and Toddlers
Pregnant Women
Classical Celiac Disease
Non-Classical Celiac Disease
Silent Celiac Disease
Refractory Celiac Disease
Potential Celiac Disease
Organic Products
Non-Organic Products
Frozen/Chilled Products
Ready-to-Eat Products
Packaged Products
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Celiac Disease Market Research Analysis
1. Introduction of the Europe Celiac Disease Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Celiac Disease Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Celiac Disease Market, By Type
6. Europe Celiac Disease Market, By Application
7. Europe Celiac Disease Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe Celiac Disease Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/